Ashwagandha for Stress: What the Trials Measured

ADVERTORIAL

HEALTH BRIEFING

What a 2021 review of seven trials actually counted

Ashwagandha for stress: what the trials measured

Perceived stress went down. So did cortisol, in the studies that measured it. The trials were short.

Wild Foods Editorial Team · Updated October 7, 2026 · Sources checked October 7, 2026

Most pages that rank for ashwagandha for stress open with a promise and close with a bottle. The NIH Office of Dietary Supplements page is duller, and more useful. It describes a 2021 review of seven human trials, 491 adults, six to eight weeks, and then it stops. No lifetime claim. No dose that works for everyone.

That gap between the marketing sentence and the trial sentence is the whole article.

"Overall, the studies found that ashwagandha significantly reduced stress and anxiety levels, reduced sleeplessness and fatigue, and reduced serum cortisol levels when compared with placebo."

NIH Office of Dietary Supplements, summarizing Lopresti and Smith, 2021

"In several studies, the benefits appeared to be greater with doses of 500 to 600 mg/day than with lower doses."

Same fact sheet, same review. Not a prescription.

"Ashwagandha appears to be well tolerated for up to about 3 months of use, but its long-term safety is not known."

NIH Office of Dietary Supplements, safety section

What people try before they look up the plant

The usual sequence is a meditation app, a later bedtime, less coffee after lunch, then a search. None of that is foolish. None of it answers whether a root extract changed a stress score in a controlled trial.

What people try What it can show What it cannot show
Cutting late caffeine Whether sleep timing was the driver How a root extract compares with placebo
A week of "feeling calmer" One person's week A validated stress scale, or a cortisol change
A product page claim What the brand hopes you will believe What the 491-person review actually measured

What the 2021 review actually included

Lopresti and Smith looked at seven studies. All 491 adults were in India. Participants had self-reported high stress, or a clinician-confirmed anxiety condition, and they were randomized to ashwagandha or placebo for 6 to 8 weeks.

The preparations were not one product. Six studies used extracts: three from root alone (KSM-66), two from root and leaf (Sensoril or Shoden), and one from unspecified parts. The seventh used dried root powder made into granules. Doses ran from 240 to 1,250 mg a day of extract, or 12,000 mg a day of whole root granules, which the fact sheet equates to 6,000 mg of root powder.

Across those studies, ashwagandha reduced stress and anxiety on validated rating scales, reduced sleeplessness and fatigue, and reduced serum cortisol compared with placebo. In several studies, 500 to 600 mg a day looked stronger than lower doses. That is a pattern inside a small set of trials, not a personal dose.

The fact sheet also notes that a specialist task force has given only a provisional nod to specific daily doses, and says it cannot go further without more data. This article is not that nod, and it is not a reason to skip clinical care.

What "less stress" meant on the page

The outcomes were rating scales, sleeplessness, fatigue, and serum cortisol. Cortisol is described as a stress hormone. A lower number on a scale is not the same thing as a lower cortisol, and a lower cortisol is not the same thing as an easy week.

SCALES

Perceived stress and anxiety

Subjective, but measured with validated rating scales, not a star rating on a product page.

A BLOOD MEASURE

Serum cortisol

Lower than placebo in the studies that reported it. Still a short-trial finding.

THE LIMIT

Six to eight weeks

The NIH says long-term safety is not known. Three months is about as far as the tolerability statement goes.

Where a product can sit, and where it cannot

KSM-66 is one of the root-only extracts named in three of the seven trials. That is a research detail about an extract, not a claim that any bottle with those letters on it reproduced the trial.

Daily Nutra KSM-66 Ashwagandha is a Wild Foods product in that extract family. This article does not list its capsule count, milligrams, or test results. Education-only means the name and the product page, not a borrowed spec sheet. It is not a stand-in for clinical care, and it is not a substitute for the clinician already following your case.

A NARROW READ

Short trials. Validated scales. A cortisol change in some of them. No long-term safety record.

If that is the standard you wanted before buying, the fact sheet is the page to keep open.

Safety, in the same voice as the benefit

In the trials above, ashwagandha was well tolerated for up to about 3 months. Common side effects were mild: stomach upset, loose stools, nausea, and drowsiness. Evidence on use over many months or years is lacking.

The fact sheet also records a few reports of more serious effects, including effects on liver function. Ashwagandha might affect thyroid function and might interact with some medicines. Some experts advise against use in pregnancy and in men with a hormone-sensitive prostate condition. Those are reasons to talk with a clinician before starting, not footnotes to skip.

See Daily Nutra KSM-66 Ashwagandha

Related reading

Questions the trials do not answer

Will 500 mg work for me?

The fact sheet says benefits appeared greater at 500 to 600 mg a day than at lower doses in several studies. That is a group pattern across different extracts. It is not a personal dose, and this article does not set one.

How long did people take it?

Six to eight weeks in the seven-trial review. Tolerability in the wider trial set is described for up to about three months. The NIH says long-term safety is not known.

Is KSM-66 the only extract in the review?

No. Three of the extract studies used KSM-66. Others used root-and-leaf extracts, an unspecified extract, or whole root granules. Pooling them is why the fact sheet will not name a single best preparation.

Who should not start without asking a clinician?

The fact sheet flags pregnancy, a hormone-sensitive prostate condition, possible thyroid effects, possible liver effects, and interactions with some medicines. Anyone in those groups, or anyone already in clinical care for anxiety, should ask before using it.

Sources

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Back to blog